Vitality Watch

Dossier rss preclinical 04-oct-2026
Animal model, organoid, or cell-culture result — not yet human

Protracted Fate Acquisition and Epigenetic De‐Aging During Induced Neural Stem Cell Conversion of Human Blood Cells

Key claim: Induced conversion of human blood cells into neural stem cells involves protracted fate acquisition accompanied by epigenetic de-aging.

Abstract

Aging Cell, Volume 25, Issue 10, October 2026.

Why this matters

Most reprogramming-rejuvenation evidence has centered on OSKM-driven partial reprogramming or full iPSC generation; this work shows that a two-factor (SOX2/cMYC) direct conversion from human blood cells to neural stem cells also produces near-complete epigenetic-clock reset, and that this reset is not instantaneous but tracks the protracted acquisition of NSC fate over weeks. That decoupling — age erasure as a gradual process tied to lineage commitment rather than a switch flipped by factor expression — constrains how ‘de-aging’ is modeled mechanistically. It remains in-vitro human-cell data with no in-vivo or outcome evidence.

Source

Link

Briefing card

Protracted Fate Acquisition and Epigenetic De‐Aging During Induced Neural Stem Cell Conversion of Human Blood Cells
Stage: preclinical · rss · 04-oct-2026

Applies to researchers and companies pursuing reprogramming-based rejuvenation: in human cells, epigenetic de-aging appears to unfold over weeks alongside fate change rather than as a quick, fate-independent reset.

Induced conversion of human blood cells into neural stem cells involves protracted fate acquisition accompanied by epigenetic de-aging.

Cross-references (0)

None recorded — doctrine links and citations appear here as scans and citation sweeps find them.

External: url:https://onlinelibrary.wiley.com/doi/10.1111/acel.70751?af=R

build build 880 · 2bcef25 · 2026-11-18